Delivery Order SPE2DB20D3101-SPE2DB22FK2Z4
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,274.01 Firm Fixed Price Delivery Order is for the supply of Tobradex Eye Ointment 3.5GM, a pharmaceutical product, with a performance period ending in April 2025. The award is not associated with a set-aside program and appears to be part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by...
- This federal contract award, identified as SPE2DB22D3102|SPE2DB25FL0LF, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tobradex Eye Ointment 3.5GM, a medical product, with a ceiling value of $1,094.46 and a completion date of March 13, 2025. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,254.44, is for the delivery of TOBREX 0.3% eye ointment in 3.5 gram tubes. The contract has a completion date of December 11, 2024 and is a Firm Fixed Price Delivery Order. This award is a part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a delivery order valued at $3,165.39 to AmerisourceBergen Drug Corp for Tobradex eye ointment (3.5 grams) on September 18, 2025, with an ultimate completion date of September 19, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $6,850.39 to supply Tobradex eye ointment (3.5 grams) under a firm fixed price contract. The award was made on July 3, 2025, with an ultimate completion date of July 7, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This non-set-aside award was competitively awarded to AmerisourceBergen, a major pharmaceutical distributor and critical federal...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of TOBREX 0.3% eye ointment in 3.5 gram units. The contract, valued at $2,805.45, is a Firm Fixed Price Delivery Order placed by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency customer for Amerisourcebergen. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, worth up to...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of TOBREX 0.3% eye ointment 3.5 grams, valued at $1,929.74. The contract is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, with a completion date of September 13, 2024. The contract is a Firm Fixed Price arrangement and does not utilize any set-aside designations. Amerisourcebergen is a major pharmaceutical distributor that holds...
- The Defense Logistics Agency awarded a $4,853.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Tobradex eye ointment (3.5 grams) on November 24, 2025, with completion by November 25, 2025. This non-set-aside competitive award represents a routine pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division for the delivery of TOBRADEX EYE OINTMENT 3.5GM. The $2,095.52 firm fixed-price delivery order has an ultimate completion date of April 22, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical through December 31, 2025, which serves as...
- This federal contract award, valued at $1,082.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TOBRADEX EYE OINTMENT 3.5GM, a medical product used for eye care. The contract has an ultimate completion date of January 28, 2025 and is structured as a Firm Fixed Price Delivery Order. This award does not have a set-aside designation, indicating open...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FK2Z4Delivery Order
This federal contract award is a Delivery Order (DO) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The DO, valued at $1,158.24, is for the supply of Tobradex Eye Ointment, a medical product used for the treatment of various eye conditions. This award is not associated with a set-aside program. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 7/1/22 |